Search Results For :: patient engagement
-
Optical Imaging Market by Product (Cameras, Lenses), Technique (OCT, HIS, NIR, PAT), Therapeutic Area (Ophthalmology, Dermatology, Oncology), Application (Pathological, Intraoperative), End User (Hospital, Research Labs) & Region - Global Forecast to 2027
The global optical Imaging market growth is primed to transition from USD 1.5 billion in 2022 to USD 2.9 billion by 2027, showcasing a strong CAGR of 13.5%. Precise differentiation between soft tissues and affected tissues, reduced patient exposure to eradicating radiations, increased prevalence of age related macular degeneration, increased GDP expenditure on healthcare among rapidly growing economies, increased need and adoption of non invasive tools for rapid scanning and identification of disorders coupled with increasing research to adopt these tools in the field of dentistry, gastroenterology, and gynecology are factors influencing the market growth and adoption of optical imaging systems.
- Published: February 2023
- Price: $ 4950
- TOC Available:
-
Pharma & Healthcare Social Media Marketing Strategies –
Increasing number of web users’ world wide (1.8 billion), development and popularity of web based community sites (Twitter, Facebook), tools and information centers (branded & unbranded sponsored communities) are changing approach towards Pharma and healthcare marketing and information sharing. In pharma industry social media has emerged as an effective tool for marketing, consumer engagement, monitoring & analyzing user generated content and building & changing brand perception. Social media is emerging as a strategic shift in organizations communication and operation model. Top pharmaceutical market players have started integrating social media in to their marketing mix. The effective social media marketing strategies that can help generate business exposure, market research data, relationship building and thus can prove as an important initiative to boom sales and overall business in the long term
- Published: August 2010
- Price: $ 4950
- TOC Available:
-
Hospital EMR Systems Market by Component (Software, Services, Hardware), Delivery Mode (Cloud, On-premise), Type (Specialty EMR), Hospital Size (Small, Large Hospitals) and Region (North America, Europe, Asia Pacific) - Global Forecasts to 2025
The global hospital EMR systems market growth is primed to transition from USD 14.2 billion in 2020 to USD 20.7 billion by 2025, showcasing a strong CAGR of 7.8%. This growth is driven by increasing hospital adoption of EMR solutions, the need to reduce healthcare costs, government mandates, and the rise in patient volume due to the COVID-19 pandemic.
- Published: June 2020
- Price: $ 4950
- TOC Available:
-
Global Minimally Invasive Surgery Market 2010 - 2015
The global minimally invasive surgery market is witnessing steady growth due to rapid technological advancements changing demographics and rising awareness amongst the patient population for less invasive procedures or single incision procedures.
- Published: October 2010
- Price: $ 4950
- TOC Available:
-
U.S. Electronic Medical Records (EMR - Physician Office & Hospital) Market - Emerging Trends (Smart Cards, Speech Enabled EMR), Market Share, Winning Strategies, Adoption & Forecasts till 2015
EMR is a part of healthcare information technology that is used to make paperless computerized patient data in order to increase efficiency of hospital systems and reduce chances of errors in medical records. A substantial growth rate (More than 16%) of the U.S. healthcare IT spending and the government initiatives towards development of a nationwide healthcare information network is expected to push EMR implementation across the healthcare sector in the U.S. The rising demand for the healthcare cost containment and need to improve the quality of healthcare service are driving the growth of the EMR market in the U.S. The U.S. EMR market is expected to grow from $2,177 million in 2009 to $6,054 million in 2015 at an estimated CAGR of 18.1% during the forecast period 2010-2015.
- Published: June 2011
- Price: $ 4950
- TOC Available:
-
Clinical Trial Services Market by Type (Laboratory, Monitoring, Recruitment, PV, Data Management), Phase (I, II, III), Therapy (Oncology, Neurology, Dermatology, CVD), Modality (Biologics, Devices), Delivery Model (FSP, Hybrid) - Global Forecast to 2030
The global Clinical Trial Services market, valued at US$60.76 billion in 2024, stood at US$66.59 billion in 2025 and is projected to advance at a resilient CAGR of 8.9% from 2025 to 2030, culminating in a forecasted valuation of US$101.86 billion by the end of the period. Factors such as the growing focus on patient-centric clinical trials such as Decentralized Clinical trials (DCTs) and the increasing number of clinical trials for precision/personalized medicines are supporting the growth of this market.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Radiotherapy Market by Technology (EBRT:MR LINAC, Stereotactic, Particle; IBRT/Brachytherapy, Cobalt-60 Teletherapy), Procedure (IGRT, IMRT, 3D-CRT, HDR, LDR, PDR), Cancer (Prostate, Breast, Lung, CRC), End User (Hospital, IRC) - Global Forecasts to 2030
The global radiotherapy market, valued at US$6.23 billion in 2022, stood at US$7.21 billion in 2024 and is projected to advance at a resilient CAGR of 4.9% from 2024 to 2030, culminating in a forecasted valuation of US$9.62 billion by the end of the period. During the forecast years, the growth of the market is attributed to the focus on advancements in radiotherapy treatment technology growing patient population, increasing initiatives to promote radiotherapy awareness.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Healthcare Mobility Solutions Market by Products & Services (Mobile Devices, Mobile Apps, Enterprise Platforms), Application (Patient Care, Operations, Workforce Management), End User (Payers, Providers, Patients) - Global Forecast to 2020
The global healthcare mobility solutions market is segmented on the basis of products and services, applications, and end users. Based on products and services, the market is segmented into mobile devices, mobile applications, and enterprise platforms. The mobile devices market covers mobile computers, RFID scanners, barcode scanners, and others. On the basis of applications, the market is classified into patient care management, operations management, and workforce management. By end users, the market is divided into payers, providers, and patients. The global healthcare mobility solutions market is expected to reach $84,817.9 Million by 2020 from $24,335.3 Million in 2015, at a CAGR of about 28.4% from 2015 to 2020.
- Published: May 2015
- Price: $ 4950
- TOC Available:
-
Guidewires Market by Material (Nitinol, Stainless Steel, Hybrid), Product (Surgical, Diagnostic (Hydrophilic, Hydrophobic)), Application (Cardiology, Vascular, Neurology, GIT, ENT, Urology, Oncology), End User (Hospital, ASCs) - Global Forecast to 2022
The global guidewires market is projected to reach USD 764.0 Million by 2022 from USD 605.2 Million in 2017, at a CAGR of 4.8%. The growth witnessed by guidewires is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for guidewires across developed countries, and rising adoption of minimally invasive surgical procedures across major countries. Major players operating in the market include Boston Scientific (US), Abbott (US), Medtronic (Ireland), Terumo (Japan), and Cook Group (US). Other prominent players present in this market include Cardinal Health (US), Olympus (Japan), Johnson & Johnson (US), B. Braun (Germany), C.R. Bard (US), Teleflex (US), and Angiodynamics (US).
- Published: February 2018
- Price: $ 4950
- TOC Available:
-
Elastomeric Infusion Pumps Market by Type (Continuous Rate and Variable Rate), Application (Chemotherapy, Pain Management, Antibiotics), End-use Industry (Hospitals, Ambulatory Surgical Centers, Home-care Settings), and Region - Global Forecast to 2030
The global elastomeric infusion pumps market, valued at US$1.09 billion in 2024, stood at US$1.15 billion in 2025 and is projected to advance at a resilient CAGR of 5.3% from 2025 to 2030, culminating in a forecasted valuation of US$1.49 billion by the end of the period. The growing prevalence of chronic illness, aging population, and rising surgical procedures drive the need for reliable, patient-friendly drug delivery systems.
- Published: November 2025
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 64
